# CardioVascular BioTherapeutics, Inc. — Form D

CardioVascular BioTherapeutics, Inc. of LAS VEGAS, NV, a company, filed a Form D exempt-offering notice with the SEC on 2015-01-14. The offering totals $49.0M. Industry: Biotechnology.

## Offering

- Filed: 2015-01-14
- Form: D
- Accession: 0001303497-15-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $49.0M
- Remaining: $49.0M
- Minimum investment: $1K
- Security types: equity
- Revenue range: $1 - $1,000,000
- SEC file number: 021-232247

## Issuer

- Name: CardioVascular BioTherapeutics, Inc.
- CIK: 0001303497
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 9500 Hillwood Drive, Suite 200A, LAS VEGAS, NV, 89134
- Phone: 702-839-7200

## Officers, directors & promoters (8)

| Name | Role | Location |
| --- | --- | --- |
| Robert Wayne Blackburn | Director | Laguna Hills, CA |
| Grant A Gordon | Director | Orange, CA |
| Al R Moran | Director | Arlington, TX |
| James R Richards | Director | Plano, TX |
| Jon A Ross | Director | Dallas, TX |
| Robert A Schleizer | Director | Dallas, TX |
| Mickael A Flaa | Executive Officer | Las Vegas, NV |
| Calvin A Wallen | Executive Officer | Dallas, TX |

## More

- [CIK 1303497 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1303497&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001303497-15-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.